«If this
strategy is effective, then it might be broadly applicable not only
against lung
cancer but also
against other
cancers that express EGFR, which include
brain, colon, and head and neck
cancers,» said Dr. Gerber, Associate Professor of Internal Medicine and Clinical Sciences.